Drug Profile
GPI 2A
Alternative Names: Anti-p24 AntisenseLatest Information Update: 07 Feb 2008
Price :
$50
*
At a glance
- Originator Viventia Biotech
- Class Antisense oligonucleotides; Antivirals
- Mechanism of Action Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections